Skip to content

Living Well with Chronic Pain

Living Well with Chronic Pain: Using Person-centered E-health Design to Support Self-management

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03705104
Acronym
EPIO
Enrollment
340
Registered
2018-10-15
Start date
2019-12-03
Completion date
2030-01-31
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Widespread

Keywords

Pain, Chronic Pain, Self-management, E-health, Appication, App, Intervention, Cognitive Behavioral Therapy, CBT, Acceptance and Commitment Therapy, ACT, Psychological well-being

Brief summary

The goal of this project is to test the effect of an interactive e-health intervention for people with chronic pain.

Detailed description

Chronic pain conditions are common and difficult to cure. As much as 30% of adults in Norway experience moderate-to-severe chronic pain, i.e., pain having lasted more than 3 months. Chronic pain is also the most common cause of sick leave and disability pension in Norway. Despite a clear request from the authorities, e-health interventions for chronic pain has not yet been tested and implemented. The aim of this study is to investigate the effect of an interactive e-health intervention for people living with chronic pain, using outcome measures such as pain intensity, pain acceptance, anxiety/depression and quality of life. The e-health intervention will first be tested in a pilot study with 50 patients with different pain diagnoses and eventually in a randomized controlled trial with a sample of 240 patients with different pain diagnoses. The intervention will consist of one face-to-face introductory group followed by 9 app-based modules containing cognitive behavioral pain self-management material. The 9 modules will be distributed over minimum 27 days (minimum 3 days per module). The participants in the randomized controlled trial will be randomly assigned to use the e-health intervention or to a treatment as usual control group. Both groups will receive outcome measures to complete at baseline and at 3, 6 and 12 months. Post-RCT, the EPIO study will also include a non-randomized group receiving the app-based EPIO program but without receiving an introduction session and follow up phone calls to examine potential benefits from receiving the app-based program only.

Interventions

BEHAVIORALEPIO

App for self-management of chronic pain An app consisting of 9 modules focusing on cognitive behavioral pain self-management.

Sponsors

The Research Council of Norway
CollaboratorOTHER
University of Oslo
CollaboratorOTHER
University College of Southeast Norway
CollaboratorOTHER
Diakonhjemmet Hospital
CollaboratorOTHER
Vestre Viken Hospital Trust
CollaboratorOTHER
Drammen municipality, Norway
CollaboratorUNKNOWN
Mayo Clinic
CollaboratorOTHER
University of Twente
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of Florida
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic pain (pain \> 3 months) * \> 18 years of age * Able to write/read/speak Norwegian * Have their own smart phone, PC or tablet

Exclusion criteria

* Cancer related pain * Migraine

Design outcomes

Primary

MeasureTime frameDescription
Brief Pain Inventory (BPI) (Short Form) - Assessing changeBaseline, and at 3, 6, and 12 months.9 item scale measuring pain interference on function. Using this measure, respondents rate their worst, least, average, and current pain intensity and also rate the degree to which pain interferes with 7 domains of functioning (general activity, mood, walking ability, normal work, relations with other persons, sleep, and enjoyment of life) on a scale of 0 to 10. There is no scoring algorithm, but worst pain or the arithmetic mean of the four severity items can be used as measures of pain severity; the arithmetic mean of the seven interference items can be used as a measure of pain interference.

Secondary

MeasureTime frameDescription
Chronic Pain Acceptance Questionnaire (CPAQ) - Assessing changeBaseline, and at 3, 6, and 12 months.8 item scale measuring pain acceptance. It is scored on a 7-point Likert scale (0 = never true; 6 = always true). Higher scores reflect higher acceptance of pain.
Self-Regulatory Fatigue 18 (SRF-18) - Assessing changeBaseline, and at 3, 6, and 12 months.18 item scale measuring self-regulatory capacity with cognitive, emotional, and behavioral components. Items are scored on a 5-point Likert scale (1 to 5). The obtainable score range is 18 to 90, with higher numbers reflecting higher SRF.
Pain Catastrophizing Scale (PCS) - Assessing changeBaseline, and at 3, 6, and 12 months.13 item scale measuring helplessness, magnification and rumination. Patients rate items on a scale from 0 (not at all) to 4 (all the time). The total score range for the PCS is 0 to 52, with higher scores reflecting higher degrees of catastrophizing.
System Usability Scale (SUS)At 3 months1o item scale measuring usability, with five response options for respondents; from Strongly agree to Strongly disagree. The obtainable score range is 25 to 100. A SUS score above a 68 would be considered above average and anything below 68 is below average.
RAND Health Related Quality of Life - Assessing changeBaseline, and at 3, 6, and 12 months.36 item scale measuring health related quality of life. The RAND-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
The Hospital Anxiety and Depression Scale (HADS) - Assessing changeBaseline, and at 3, 6, and 12 months.14 item scale measuring anxiety and depression. Respondents are asked to indicate which of 4 response options (rated from 0-3; score range, 0-42) comes closest to describing how they have been feeling in the previous week for each item. Scores from 0-7 on the subscales are regarded as being in the normal range; a score of 11 or higher indicates a probable presence of a mood disorder, and a score of 8-10 is suggestive of the presence of the state.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026